dc.contributor.author | Kosgei, R J | |
dc.contributor.author | Szkwarko, D | |
dc.contributor.author | Callen, S | |
dc.contributor.author | Gichangi, P | |
dc.contributor.author | Temmerman, M | |
dc.contributor.author | Kihara, A B | |
dc.contributor.author | Sitienei, J J | |
dc.contributor.author | Cheserem, E J | |
dc.contributor.author | Ndavi, P M | |
dc.contributor.author | Reid, A J | |
dc.contributor.author | Carter, E J | |
dc.date.accessioned | 2015-03-09T12:33:41Z | |
dc.date.available | 2015-03-09T12:33:41Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Kosgei, R. J., Szkwarko, D., Callens, S., Gichangi, P., Temmerman, M., Kihara, A. B., ... & Carter, E. J. (2013). Screening for tuberculosis in pregnancy: do we need more than a symptom screen? Experience from western Kenya. Public Health Action, 3(4), 294-298. | en_US |
dc.identifier.uri | http://hdl.handle.net/11295/81067 | |
dc.description.abstract | Objectives:
1) To
explore the utility of tuberculosis (TB)
symptom screening for symptoms of
⩾
2 weeks’ duration
in a routine setting, and 2) to compare differences in TB
diagnosis between human immunodeficiency virus (HIV)
infected and non-HIV-infected pregnant women in west-
ern Kenya.
Design:
Comparative cross-sectional study among preg-
nant women with known HIV status screened for TB from
2010 to 2012, in Eldoret, western Kenya.
Results:
Of 2983 participants, respectively 34 (1%),
1488 (50.5%) and 1461 (49.5%) had unknown, positive
and negative HIV status. The median age was respectively
30 years (interquartile range [IQR] 26–35) and 26 years
(IQR 24–31) in HIV-infected and non-infected participants.
A positive symptom screen was found in respectively
8% (119/1488) and 5% (67/1461) of the HIV-infected
and non-infected women. The median CD4 count at en-
rolment was 377 cells/
μ
l (IQR 244–530) for HIV-infected
women. One non-HIV-infected patient was sputum-
p
ositive. For HIV-infected women, TB was presumptively
treated in 1% (16/1488) based on clinical symptoms and
chest X-ray. Cumulatively, anti-tuberculosis treatment was
offered to 0.6% (17/2949) of the participants.
Conclusion:
This study does not seem to demonstrate the
utility of TB symptom screening questionnaires in a rou-
tine setting among pregnant women, either HIV-infected
or non-infected, in western Kenya. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.title | Screening for tuberculosis in pregnancy: do we need more than a symptom screen? Experience from western Kenya | en_US |
dc.type | Article | en_US |
dc.type.material | en_US | en_US |